Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Vysotskaia
EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated With Lapatinib Resistance and Neoplastic Transformation
Clinical Cancer Research
Cancer Research
Oncology
Related publications
ErbB2 Inhibition by Lapatinib Promotes Degradation of Mutant P53 Protein in Cancer Cells
Oncotarget
Oncology
B-Myc Inhibits Neoplastic Transformation and Transcriptional Activation by C-Myc.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Differential Sensitivity of ERBB2 Kinase Domain Mutations Towards Lapatinib
PLoS ONE
Multidisciplinary
An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Targeted Lapatinib Anti-Her2/ErbB2 Therapy Resistance in Breast Cancer: Opportunities to Overcome a Difficult Problem
Spectrum of Renal Diseases Associated With Extreme Forms of Insulin Resistance
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Sequence Variants and Haplotype Analysis of Cat ERBB2 Gene: A Survey on Spontaneous Cat Mammary Neoplastic and Non-Neoplastic Lesions
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
ErbB2 Trafficking and Degradation Associated With K48 and K63 Polyubiquitination
Cancer Research
Cancer Research
Oncology
